{
    "code": "60001150",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001150",
    "time": "2021-12-17 03:45:23",
    "許可證字號": "衛部菌疫輸字第001150號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/05\/19",
    "發證\/登錄日期": "110\/05\/19",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000115003",
    "中文品名": "必思諾B型腦膜炎雙球菌疫苗",
    "英文品名": "Bexsero Meningococcal Group B Vaccine",
    "適應症": "適用於2個月以上兒童及成人之主動免疫接種，以預防B型奈瑟氏腦膜炎雙球菌所引起的侵入性腦膜炎雙球菌疾病。",
    "劑型": "27A懸浮注射液",
    "包裝": "單劑量0.5mL玻璃預充填注射針筒附或不附針頭，100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "疫苗_新成分",
    "監視期限": "115\/05\/19",
    "主成分略述": "Recombinant Neisseria meningitidis group B NHBA fusion protein (Rp287-953), Recombinant Neisseria meningitidis group B NadA protein (Rp961c), Recombinant Neisseria meningitidis group B fHbp fusion protein (Rp936-741), Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98\/254 measured as amount of total protein containing the PorA P1.4",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "0901801100  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
    "主製造廠": [
        {
            "": "ITALY",
            "製程": "調液、充填及包裝作業；含原料藥製造"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "1225204000  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FAT0007000  Sandoz GmbH",
            "製造廠廠址": "BIOCHEMIESTRASSE 10, 6250 KUNDL AUSTRIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRIA",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8008004010",
            "成分名稱": "Recombinant Neisseria meningitidis group B NHBA fusion protein (Rp287-953)",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8008004020",
            "成分名稱": "Recombinant Neisseria meningitidis group B NadA protein (Rp961c)",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8008004030",
            "成分名稱": "Recombinant Neisseria meningitidis group B fHbp fusion protein (Rp936-741)",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8008004040",
            "成分名稱": "Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98\/254 measured as amount of total protein containing the PorA P1.4",
            "含量描述": "",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020011500004_仿單-110-06-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001150&Seq=001&Type=9"
        },
        {
            "title": "020011500002_Label_507505-110-09-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001150&Seq=004&Type=8"
        },
        {
            "title": "020011500001_Carton_507503-110-09-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001150&Seq=003&Type=8"
        }
    ]
}